The dsRNA ‐binding protein OsDRB1.4 is phosphorylated by OsMPK5 and negatively regulates rice defense against Magnaporthe oryzae
The Plant Journal · 2025
DOI: 10.1111/tpj.70285 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Plant Journal, 2025. Verfasst von Yuedan Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Crop Genetic Improvement, Hubei Hongshan Laboratory, Huazhong Agricultural University, Wuhan, 430070, China. Hauptthemen laut MEDLINE: Oryza, Plant Diseases, Plant Proteins, RNA-Binding Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 98 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
Plant mitogen‐activated protein kinases (MAPKs) are pivotal regulators of the innate immune signaling pathway and phosphorylate an array of transcription factors to reprogram the expression of disease‐responsive genes. However, how MAPKs reprogram plant gene expression at the posttranscriptional level is poorly understood. Here, we show that double‐stranded RNA‐binding protein 1.4 (OsDRB1.4) is a substrate of OsMPK5 in rice. OsDRB1.4 belongs to a monocot‐specific subgroup of the DRB family and contains a noncanonical MAPK interaction motif in its C terminus. OsMPK5 mainly phosphorylates the 216th serine of OsDRB1.4 in vivo . Silencing and knockout of OsDRB1.4 increased rice defense against Magnaporthe oryzae and increased the expression of 34 genes, including PR5 and three R‐GENE ANALOG genes, whereas OsDRB1.4 ‐overexpressing rice was more susceptible to blast disease. In contrast, overexpressing OsDRB1.4 with the phosphorylation sites mutated in rice did not affect disease susceptibility, suggesting that these phosphorylation sites are critical for OsDRB1.4 functionality. A total of 130 transcript units and 171 annotated repetitive sequence transcripts were identified as the RNA partners of OsDRB1.4 through targeted RNA editing. RNA electrophoretic mobility shift assays validated that OsDRB1.4 directly bound the stem‐loop dsRNAs of microRNA precursors and the 3′‐UTRs of protein‐coding mRNAs. Further analysis indicated that OsDRB1.4 positively regulated the expression of mature osa‐miR7695 and osa‐miR2871. More importantly, OsDRB1.4 bound stem‐loop dsRNA in the 3′‐UTR of Pi‐ta RESISTANCE ( Ptr ) and negatively affected protein expression. Together, our data reveal that the OsMPK5‐OsDRB1.4 module negatively regulates rice defense against M. oryzae through the posttranscriptional suppression of defense‐related genes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of Crop Genetic Improvement, Hubei Hongshan Laboratory, Huazhong Agricultural University, Wuhan, 430070, China.
- Hubei Key Laboratory of Plant Pathology, College of Plant Science and Technology, Huazhong Agricultural University, Wuhan, 430070, China.
- Department of Plant Pathology and Environmental Microbiology, The Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, Pennsylvania, 16802, USA.
ORCID-Profile: Kabin Xie
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Chen, Y., Yin, S., Yang, Y., & Xie, K. (2025). The dsRNA ‐binding protein OsDRB1.4 is phosphorylated by OsMPK5 and negatively regulates rice defense against Magnaporthe oryzae. The Plant Journal. https://doi.org/10.1111/tpj.70285
Vancouver
Chen Y, Yin S, Yang Y, Xie K. The dsRNA ‐binding protein OsDRB1.4 is phosphorylated by OsMPK5 and negatively regulates rice defense against Magnaporthe oryzae. The Plant Journal. 2025. doi:10.1111/tpj.70285
BibTeX
@article{Chen2025,
author = {Chen, Yuedan and Yin, Shuai and Yang, Yinong and Xie, Kabin},
title = {The dsRNA ‐binding protein OsDRB1.4 is phosphorylated by OsMPK5 and negatively regulates rice defense against Magnaporthe oryzae},
journal = {The Plant Journal},
year = {2025},
doi = {10.1111/tpj.70285}
}
EUVIMED